| Revenue | DKK -16K | -3% |
| EBITDA | DKK -16K | +3% |
| Net profit | DKK 545K | +406% |
| Total assets | DKK 1M | +132% |
| Equity | DKK 770K | +242% |
| Employees | — | — |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -95 | 97 | -4 | 0 | 0 | 0 | -5 | 0 | -15 | -20 | -16 | -16 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -95 | 97 | -4 | 0 | 0 | 0 | -5 | -10 | -15 | -20 | -16 | -16 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -95 | 97 | -4 | 0 | 0 | 0 | -5 | -10 | -15 | -20 | -16 | -16 |
| Net financials | -90 | 101 | 41 | 43 | 82 | 0 | 93 | 101 | 240 | 99 | 120 | 554 |
| Profit before tax | -95 | 96 | 37 | 43 | 82 | 0 | 88 | 91 | 225 | 80 | 103 | 538 |
| Tax | -0 | -1 | -1 | -0 | -0 | -0 | -1 | -2 | -1 | -1 | -4 | -7 |
| Net profit | -95 | 97 | 38 | 43 | 82 | 0 | 89 | 93 | 226 | 81 | 108 | 545 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 68 | 169 | 169 | 124 | 163 | 84 | 178 | 228 | 372 | 314 | 433 | 1.004 |
| Equity | 60 | 69 | 112 | 82 | 82 | 84 | 173 | 216 | 347 | 118 | 225 | 770 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 8 | 101 | 57 | 43 | 82 | 0 | 5 | 12 | 25 | 197 | 208 | 234 |
| Total debt | 8 | 101 | 57 | 43 | 82 | 0 | 5 | 12 | 25 | 197 | 208 | 234 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CL Founder | Founder | 2013 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50.0% | 50.0% | 2026 | |
KRINGELUM SCIENCES ApS | Company | 33.3% | 33.3% | 2026 |
| Individual | 20.0% | 20.0% | 2014 |
| Person | Role here | Other companies |
|---|---|---|
| Claus Lundegaard | Founder | 0 companies |